The first market is witnessing robust exercise as three mainboard preliminary public choices (IPOs), specifically, Symbiotec Pharmalab, Hy-Tech Engineers, and Skyways Air, opened for subscription concurrently, collectively searching for to lift over Rs 2,475 crore.
Representing various sectors starting from energetic pharmaceutical substances (APIs) and industrial element manufacturing to international air cargo and logistics, these choices cater to a wide selection of funding profiles.
Skyways Air vs Symbiotec Pharmalab vs Hy-Tech Engineers IPO GMP In contrast
| IPO | GMP | Implied Itemizing Acquire |
| Hy-Tech Engineers | Rs 25 | 47.17% |
| Symbiotec Pharmalab | Rs 403 | 40.79% |
| Skyways Air | Rs 31 | 22.46% |
Among the many three IPOs, Hy-Tech Engineers at the moment has the very best implied itemizing acquire at 47.17%, adopted by Symbiotec Pharmalab at 41.40% and Skyways Air at 23.19%, based mostly on GMP estimates as of 9:30 a.m. on Aug. 24.
The general public problems with Symbiotec Pharmalab, Hy-Tech Engineers, and Skyways Air opened for subscription on Aug. 24 and can shut on Aug. 27.
Buyers are intently analysing subscription ranges, market tendencies, and gray market premium figures for indications of preliminary buying and selling behaviour.
Here’s a detailed have a look at the most recent GMP and key IPO particulars for every problem.
Skyways Air IPO GMP Right this moment
Skyways Air IPO’s newest gray market premium stands at Rs 31 at 11:30 a.m. on Aug. 24. Including the Rs 31 GMP to the higher value band of Rs 138 offers an implied itemizing value of Rs 169. This interprets into an implied itemizing acquire of twenty-two.46% over the higher problem value.
Skyways Air IPO Newest Subscription Standing
The Skyways Air IPO was subscribed 0.52 times as of 12:30 p.m. on Monday.
Skyways Air IPO Particulars
Skyways Air IPO is a book-built problem of Rs 582.80 crore. The problem includes a contemporary problem of Rs 398.80 crore and an OFS element of Rs 184 crore.
The share allotment course of is anticipated to be finalised on Aug. 28, with tentative itemizing on the BSE and NSE on Sep. 1.
The problem value band has been set at Rs 131 to Rs 138 per share. The lot dimension for an utility is 100 shares, requiring a minimal retail funding of Rs 13,800.
Holani Consultants Pvt. Ltd. is the book-running lead supervisor and Bigshare Providers Pvt. Ltd. is the registrar.
Skyways Air Providers is an air cargo and logistics companies supplier providing worldwide freight forwarding and provide chain options.
Symbiotec Pharmalab IPO GMP Right this moment
Symbiotec Pharmalab IPO’s newest gray market premium stands at Rs 403 as of Aug. 24 at 11:30 a.m. Including the Rs 403 GMP to the higher value band of Rs 988 offers an implied itemizing value of Rs 1,391. This interprets into an implied itemizing acquire of 40.79% over the higher problem value.
Symbiotec Pharmalab IPO Newest Subscription Standing
The Symbiotec Pharmalab IPO was subscribed 0.32 times as of 12:30 p.m. on Monday.
Symbiotec Pharmalab IPO Particulars
A book-built problem of Rs 1,757 crore, this problem includes a contemporary problem price Rs 150 crore and an offer-for-sale (OFS) of Rs 1,607 crore. Share allotment is anticipated to be finalised on Aug. 28, with itemizing scheduled on the BSE and NSE on Sep. 1.
The problem value band is ready at Rs 938–Rs 988 per share. Every utility lot consists of 15 shares, requiring retail buyers to bid a minimal quantity of Rs 14,820 (based mostly on the higher value band).
JM Monetary Ltd. is the book-running lead supervisor and MUFG Intime India Pvt. Ltd. is the registrar of the problem.
Symbiotec Pharmalab is an energetic pharmaceutical substances (API) manufacturing firm specialising in steroid and hormone merchandise for international healthcare markets.
Hy-Tech Engineers IPO GMP Right this moment
Hy-Tech Engineers shares had been commanding a gray market premium of Rs 25 as of Aug. 24 at 11:30 a.m. The IPO has set its higher value band at Rs 53 a share, taking the implied itemizing worth to Rs 78 when the most recent GMP is added. The calculation factors to a 47.17% itemizing upside from the higher problem value.
Hy-Tech Engineers IPO Newest Subscription Standing
The Hy-Tech Engineers IPO was subscribed 3.31 times as of 12:30 p.m. on Monday.
Hy-Tech Engineers IPO Particulars
Hy-Tech Engineers IPO is a mainboard problem of Rs 135.73 crore. The problem includes a contemporary problem of Rs 60 crore and an OFS element of Rs 75.73 crore.
The share allotment course of is anticipated to be finalised on Aug. 28, with tentative itemizing on the BSE and NSE on Sep. 1.
The problem value band has been set at Rs 50 to Rs 53 per share. Lot dimension for an utility is 283 shares, requiring a minimal retail funding of Rs 14,999.
New Berry Capitals Pvt. Ltd. is the book-running lead supervisor and Bigshare Providers Pvt. Ltd. is the registrar.
ALSO READ | SEBI To Examine ‘Permitted-To-Trade’ Framework For NSE
Hy-Tech Engineers manufactures and provides hydraulic fittings, engineering equipment, and industrial elements.
Symbiotec Pharmalab vs Hy-Tech Engineers vs Skyways Air IPO GMP — Which Is Higher?
Hy-Tech Engineers IPO leads the three points each in implied proportion itemizing acquire and estimated rupee acquire per retail lot. With a gray market premium of Rs 25 over an higher value band of Rs 53, it factors to a possible itemizing upside of 47.17%. Owing to its bigger lot dimension of 283 shares, this interprets to an estimated revenue of Rs 7,075 per retail utility lot (Rs 25 × 283).
Symbiotec Pharmalab IPO follows intently in proportion phrases with an anticipated itemizing acquire of 40.79% based mostly on a GMP of Rs 403 over its higher value band of Rs 988. Given its lot dimension of 15 shares, it provides an estimated absolute return of Rs 6,135 per retail lot.
Skyways Air IPO ranks third among the many three choices, that includes a GMP of Rs 31 over an higher value band of Rs 138, translating into an estimated itemizing upside of twenty-two.46% and an anticipated return of Rs 3,200 per lot (100 shares).
Observe: GMP doesn’t characterize official information and relies on hypothesis.
Disclaimer: Investments in preliminary public choices are topic to market dangers. Please seek the advice of with monetary advisors and browse the pink herring prospectus completely earlier than putting bids.
Important Business Intelligence,
Sharp Market Insights,
Sensible Personal Finance Recommendation, Every day Fuel, Gold and Silver Costs and Latest Tales — On NDTV Revenue.
